3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
30
Glioblastoma
28
Breast Neoplasms
19
Lung Neoplasms
17
Carcinoma, Non-Small-Cell Lung
17
Oropharyngeal Neoplasms
14
Squamous Cell Carcinoma of Head and Neck
11
Sarcoma
10
Glioma
10
Esophageal Neoplasms
10
Brain Neoplasms
10
Urinary Bladder Neoplasms
9
Astrocytoma
9
Gliosarcoma
8
Triple Negative Breast Neoplasms
7
Neoplasm Metastasis
7
Mouth Neoplasms
7
Uterine Cervical Neoplasms
6
Rectal Neoplasms
6
Melanoma
6
Head and Neck Neoplasms
6
Carcinoma, Hepatocellular
6
Carcinoma
6
Adenocarcinoma Of Esophagus
6
Stomach Neoplasms
5
Pancreatic Neoplasms
5
Neoplasms
5
Laryngeal Neoplasms
5
Esophageal Squamous Cell Carcinoma
5
Carcinoma, Squamous Cell
5
Interventions
pembrolizumab
12
Pemetrexed
9
Cisplatin
9
Nivolumab
8
Carboplatin
8
Ipilimumab
7
Cyclophosphamide
6
fludarabine
5
durvalumab
4
tremelimumab
2
Radiotherapy, Intensity-Modulated
2
Gemcitabine
2
Cerebral Decortication
2
tocilizumab
1
tislelizumab
1
tazemetostat
1
sotorasib
1
ruxolitinib
1
osimertinib
1
olaparib
1
obinutuzumab
1
naptumomab estafenatox
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
bintrafusp alfa protein, human
1
avelumab
1
atezolizumab
1
Tumor Burden
1
Tablets
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
Radiation
×
1 year
×
Clear all
No trials found.